Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals

Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 2003-09, Vol.52 (3), p.507-510
Hauptverfasser: Randall, L. P., Ridley, A. M., Cooles, S. W., Sharma, M., Sayers, A. R., Pumbwe, L., Newell, D. G., Piddock, L. J. V., Woodward, M. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 510
container_issue 3
container_start_page 507
container_title Journal of antimicrobial chemotherapy
container_volume 52
creator Randall, L. P.
Ridley, A. M.
Cooles, S. W.
Sharma, M.
Sayers, A. R.
Pumbwe, L.
Newell, D. G.
Piddock, L. J. V.
Woodward, M. J.
description Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P < 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.
doi_str_mv 10.1093/jac/dkg379
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19260944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>431327361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-801ae7c6a6f7bd0b62ed3b474bb7ebaeb814c299eb606d6c38a8afede26f93e13</originalsourceid><addsrcrecordid>eNpdkU1r3DAQhkVpaDbbXvoDiii0h4ITyZIl6xg2TbcQ-gEtlF6EJI9TbWTLleyQ_Psq7NJADsMc5uFl5hmEXlNySoliZzvjzrqbaybVM7SiXJCqJoo-RyvCSFNJ3rBjdJLzjhAiGtG-QMe0VlTWnK7Q9bcEtybA6ADHHg9LmP0UAJtx9tbH2TucIPs8mwfCj5hzhjdmmO5DtMbNkHCeplPscwxmhg73KQ74zzKYMZeQrpQfTMgv0VFfGrw69DX6efnxx2ZbXX399HlzflU5TtRctYQakE4Y0UvbEStq6JjlklsrwRqwLeWuVgqsIKITjrWmNT10UIteMaBsjd7vc6cU_y6QZz347CAEM0JcsqaqFkSVI9bo7RNwF5c0lt10TaUQpOgp0Ic95FLMOUGvp1TOSfeaEv3gXhf3eu--wG8OiYsdoHtED7IL8O4AmOxM6FNx6vMj15SvcdoWrtpzRTvc_Z-bdKOFZLLR21-_9bb9ri4uKNVf2D9v4p02</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217660241</pqid></control><display><type>article</type><title>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Randall, L. P. ; Ridley, A. M. ; Cooles, S. W. ; Sharma, M. ; Sayers, A. R. ; Pumbwe, L. ; Newell, D. G. ; Piddock, L. J. V. ; Woodward, M. J.</creator><creatorcontrib>Randall, L. P. ; Ridley, A. M. ; Cooles, S. W. ; Sharma, M. ; Sayers, A. R. ; Pumbwe, L. ; Newell, D. G. ; Piddock, L. J. V. ; Woodward, M. J.</creatorcontrib><description>Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P &lt; 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.</description><identifier>ISSN: 0305-7453</identifier><identifier>ISSN: 1460-2091</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkg379</identifier><identifier>PMID: 12917241</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; beta-Lactamases - metabolism ; Biological and medical sciences ; Campylobacter - drug effects ; Campylobacter - genetics ; Campylobacter - metabolism ; Campylobacter coli ; Campylobacter Infections - microbiology ; Campylobacter jejuni ; cmeABC ; Coloring Agents - pharmacology ; Disinfectants - pharmacology ; Drug Resistance, Multiple, Bacterial ; efflux ; ethidium bromide ; Genes, MDR - genetics ; Herbicides - pharmacology ; Humans ; Medical sciences ; Microbial Sensitivity Tests ; Paraquat - pharmacology ; Pharmacology. Drug treatments ; Phenotype ; salicylate ; Salicylates - pharmacology ; Solvents</subject><ispartof>Journal of antimicrobial chemotherapy, 2003-09, Vol.52 (3), p.507-510</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Sep 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-801ae7c6a6f7bd0b62ed3b474bb7ebaeb814c299eb606d6c38a8afede26f93e13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15091418$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12917241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Randall, L. P.</creatorcontrib><creatorcontrib>Ridley, A. M.</creatorcontrib><creatorcontrib>Cooles, S. W.</creatorcontrib><creatorcontrib>Sharma, M.</creatorcontrib><creatorcontrib>Sayers, A. R.</creatorcontrib><creatorcontrib>Pumbwe, L.</creatorcontrib><creatorcontrib>Newell, D. G.</creatorcontrib><creatorcontrib>Piddock, L. J. V.</creatorcontrib><creatorcontrib>Woodward, M. J.</creatorcontrib><title>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J. Antimicrob. Chemother</addtitle><description>Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P &lt; 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>beta-Lactamases - metabolism</subject><subject>Biological and medical sciences</subject><subject>Campylobacter - drug effects</subject><subject>Campylobacter - genetics</subject><subject>Campylobacter - metabolism</subject><subject>Campylobacter coli</subject><subject>Campylobacter Infections - microbiology</subject><subject>Campylobacter jejuni</subject><subject>cmeABC</subject><subject>Coloring Agents - pharmacology</subject><subject>Disinfectants - pharmacology</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>efflux</subject><subject>ethidium bromide</subject><subject>Genes, MDR - genetics</subject><subject>Herbicides - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Paraquat - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>salicylate</subject><subject>Salicylates - pharmacology</subject><subject>Solvents</subject><issn>0305-7453</issn><issn>1460-2091</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1r3DAQhkVpaDbbXvoDiii0h4ITyZIl6xg2TbcQ-gEtlF6EJI9TbWTLleyQ_Psq7NJADsMc5uFl5hmEXlNySoliZzvjzrqbaybVM7SiXJCqJoo-RyvCSFNJ3rBjdJLzjhAiGtG-QMe0VlTWnK7Q9bcEtybA6ADHHg9LmP0UAJtx9tbH2TucIPs8mwfCj5hzhjdmmO5DtMbNkHCeplPscwxmhg73KQ74zzKYMZeQrpQfTMgv0VFfGrw69DX6efnxx2ZbXX399HlzflU5TtRctYQakE4Y0UvbEStq6JjlklsrwRqwLeWuVgqsIKITjrWmNT10UIteMaBsjd7vc6cU_y6QZz347CAEM0JcsqaqFkSVI9bo7RNwF5c0lt10TaUQpOgp0Ic95FLMOUGvp1TOSfeaEv3gXhf3eu--wG8OiYsdoHtED7IL8O4AmOxM6FNx6vMj15SvcdoWrtpzRTvc_Z-bdKOFZLLR21-_9bb9ri4uKNVf2D9v4p02</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Randall, L. P.</creator><creator>Ridley, A. M.</creator><creator>Cooles, S. W.</creator><creator>Sharma, M.</creator><creator>Sayers, A. R.</creator><creator>Pumbwe, L.</creator><creator>Newell, D. G.</creator><creator>Piddock, L. J. V.</creator><creator>Woodward, M. J.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20030901</creationdate><title>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</title><author>Randall, L. P. ; Ridley, A. M. ; Cooles, S. W. ; Sharma, M. ; Sayers, A. R. ; Pumbwe, L. ; Newell, D. G. ; Piddock, L. J. V. ; Woodward, M. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-801ae7c6a6f7bd0b62ed3b474bb7ebaeb814c299eb606d6c38a8afede26f93e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>beta-Lactamases - metabolism</topic><topic>Biological and medical sciences</topic><topic>Campylobacter - drug effects</topic><topic>Campylobacter - genetics</topic><topic>Campylobacter - metabolism</topic><topic>Campylobacter coli</topic><topic>Campylobacter Infections - microbiology</topic><topic>Campylobacter jejuni</topic><topic>cmeABC</topic><topic>Coloring Agents - pharmacology</topic><topic>Disinfectants - pharmacology</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>efflux</topic><topic>ethidium bromide</topic><topic>Genes, MDR - genetics</topic><topic>Herbicides - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Paraquat - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>salicylate</topic><topic>Salicylates - pharmacology</topic><topic>Solvents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Randall, L. P.</creatorcontrib><creatorcontrib>Ridley, A. M.</creatorcontrib><creatorcontrib>Cooles, S. W.</creatorcontrib><creatorcontrib>Sharma, M.</creatorcontrib><creatorcontrib>Sayers, A. R.</creatorcontrib><creatorcontrib>Pumbwe, L.</creatorcontrib><creatorcontrib>Newell, D. G.</creatorcontrib><creatorcontrib>Piddock, L. J. V.</creatorcontrib><creatorcontrib>Woodward, M. J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Randall, L. P.</au><au>Ridley, A. M.</au><au>Cooles, S. W.</au><au>Sharma, M.</au><au>Sayers, A. R.</au><au>Pumbwe, L.</au><au>Newell, D. G.</au><au>Piddock, L. J. V.</au><au>Woodward, M. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J. Antimicrob. Chemother</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>52</volume><issue>3</issue><spage>507</spage><epage>510</epage><pages>507-510</pages><issn>0305-7453</issn><issn>1460-2091</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>Aims: In view of recent findings that a multidrug efflux pump CmeABC exists in Campylobacter jejuni, 391 C. jejuni and 52 Campylobacter coli of human and animal origin were examined for a multidrug resistance phenotype. Materials and methods: The MICs of ampicillin, chloramphenicol, ciprofloxacin, erythromycin, kanamycin, tetracycline, cetrimide, triclosan, acridine orange, paraquat and ethidium bromide were determined. Resistance to organic solvents and the effect of salicylate (known inducer of the marRAB operon in Escherichia coli and Salmonella) were also examined. Results: Two C. coli and 13 C. jejuni isolates, mainly from pigs or poultry, were resistant to three or more antibiotics and 12 of these strains had reduced susceptibility to acridine orange and/or ethidium bromide. Strains (n = 20) that were less susceptible to acridine orange, ethidium bromide and triclosan were significantly more resistant (P &lt; 0.05) to ampicillin, chloramphenicol, ciprofloxacin, erythromycin, nalidixic acid and tetracycline, with two- to four-fold increases in MIC values compared with strains (n = 20) most susceptible to acridine orange, ethidium bromide and triclosan. Growth of strains with 1 mM salicylate caused a small (up to two-fold) but statistically significant (P ≤ 0.005) increase in the MICs of chloramphenicol, ciprofloxacin, erythromycin and tetracycline. Conclusions: These data indicate that multiple antibiotic resistant (MAR)-like Campylobacter strains occur and it may be postulated that these may overexpress cmeABC or another efflux system.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>12917241</pmid><doi>10.1093/jac/dkg379</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2003-09, Vol.52 (3), p.507-510
issn 0305-7453
1460-2091
1460-2091
language eng
recordid cdi_proquest_miscellaneous_19260944
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Animals
Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
beta-Lactamases - metabolism
Biological and medical sciences
Campylobacter - drug effects
Campylobacter - genetics
Campylobacter - metabolism
Campylobacter coli
Campylobacter Infections - microbiology
Campylobacter jejuni
cmeABC
Coloring Agents - pharmacology
Disinfectants - pharmacology
Drug Resistance, Multiple, Bacterial
efflux
ethidium bromide
Genes, MDR - genetics
Herbicides - pharmacology
Humans
Medical sciences
Microbial Sensitivity Tests
Paraquat - pharmacology
Pharmacology. Drug treatments
Phenotype
salicylate
Salicylates - pharmacology
Solvents
title Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A53%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20multiple%20antibiotic%20resistance%20in%20443%20Campylobacter%20spp.%20isolated%20from%20humans%20and%20animals&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Randall,%20L.%20P.&rft.date=2003-09-01&rft.volume=52&rft.issue=3&rft.spage=507&rft.epage=510&rft.pages=507-510&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/dkg379&rft_dat=%3Cproquest_cross%3E431327361%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217660241&rft_id=info:pmid/12917241&rfr_iscdi=true